Translate Bio Provides Updates on Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency Programs

    NEXT STORY
    Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting
    PREV STORY
    BeiGene Reports Fourth Quarter and Full Year 2018 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Blood Processing Devices and Consumables Market is Expected to Hit US$ 64.25 Billion By 2026: Credence Research

    SAN JOSE, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- According to the latest report ...

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences to Host Conference Call on November 10, 2017 to Report Third Quarter 2017 Financial Results and Corporate Performance

    MADISON, Wis., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

    author_avatar
    NASDAQ Market News

    Global Precision Medicine Market 2018-2028 with 2017 as the Base Year – Market to Reach $216.75 Billion

    Dublin, Feb. 06, 2019 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market: Focus on ...

    author_avatar
    NASDAQ Market News